“…Other SNPs with an impact on steroid-induced osteonecrosis have been demonstrated for cytochrome P450 and associated with lower risk [ 25 ], whereas different IL1B polymorphisms influence the risk for steroid-induced osteonecrosis [ 26 ]. Metalloproteinase 2, 8, and 10 polymorphisms contribute to susceptibility [ 27 , 28 ], as RETN (coding for resistin, an adipokine involved in metabolic disorders) and ApoA 5 and APOE (involved in lipid metabolism) SNP [ [29] , [30] , [31] ]. In contrast, metalloproteinase 9 SNPs appears to reduce the risk [ 32 ], similar to the gene for the tissue inhibitor of metalloprotease-4 [ 33 ], while the plasminogen activator inhibitor-1 (PAI-1) SNP has been demonstrated to be associated with an increased risk of steroid-induced osteonecrosis [ 34 ].…”